150 related articles for article (PubMed ID: 35269729)
1. The Antidepressant Duloxetine Inhibits Platelet Function and Protects against Thrombosis.
Lozano PA; Alarabi AB; Garcia SE; Boakye ET; Kingbong HT; Naddour E; Villalobos-García D; Badejo P; El-Halawany MS; Khasawneh FT; Alshbool FZ
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269729
[TBL] [Abstract][Full Text] [Related]
2. The antidepressant 5-HT2A receptor antagonists pizotifen and cyproheptadine inhibit serotonin-enhanced platelet function.
Lin OA; Karim ZA; Vemana HP; Espinosa EV; Khasawneh FT
PLoS One; 2014; 9(1):e87026. PubMed ID: 24466319
[TBL] [Abstract][Full Text] [Related]
3. NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis.
Qiao J; Wu X; Luo Q; Wei G; Xu M; Wu Y; Liu Y; Li X; Zi J; Ju W; Fu L; Chen C; Wu Q; Zhu S; Qi K; Li D; Li Z; Andrews RK; Zeng L; Gardiner EE; Xu K
Haematologica; 2018 Sep; 103(9):1568-1576. PubMed ID: 29794149
[TBL] [Abstract][Full Text] [Related]
4. Duloxetine plasma level and antidepressant response.
De Donatis D; Florio V; Porcelli S; Saria A; Mercolini L; Serretti A; Conca A
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():127-132. PubMed ID: 30611837
[TBL] [Abstract][Full Text] [Related]
5. The Antithrombotic Agent Pterostilbene Interferes with Integrin α
Huang WC; Lin KC; Hsia CW; Hsia CH; Chen TY; Bhavan PS; Sheu JR; Hou SM
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807403
[TBL] [Abstract][Full Text] [Related]
6. Serotonin and Norepinephrine Reuptake Inhibitors.
Shelton RC
Handb Exp Pharmacol; 2019; 250():145-180. PubMed ID: 30838456
[TBL] [Abstract][Full Text] [Related]
7. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
[TBL] [Abstract][Full Text] [Related]
9. Duloxetine effects on striatal resting-state functional connectivity in patients with major depressive disorder.
Wang L; An J; Gao HM; Zhang P; Chen C; Li K; Mitchell PB; Si TM
Hum Brain Mapp; 2019 Aug; 40(11):3338-3346. PubMed ID: 31066977
[TBL] [Abstract][Full Text] [Related]
10. Effect of duloxetine on changes in serum proinflammatory cytokine levels in patients with major depressive disorder.
Gao W; Gao Y; Xu Y; Liang J; Sun Y; Zhang Y; Shan F; Ge J; Xia Q
BMC Psychiatry; 2024 Jun; 24(1):449. PubMed ID: 38877455
[TBL] [Abstract][Full Text] [Related]
11. Full activation of mouse platelets requires ADP secretion regulated by SERCA3 ATPase-dependent calcium stores.
Elaïb Z; Adam F; Berrou E; Bordet JC; Prévost N; Bobe R; Bryckaert M; Rosa JP
Blood; 2016 Aug; 128(8):1129-38. PubMed ID: 27301859
[TBL] [Abstract][Full Text] [Related]
12. The G-protein βγ subunits regulate platelet function.
Alarabi AB; Karim ZA; Hinojos V; Lozano PA; Hernandez KR; Montes Ramirez JE; Ali HEA; Khasawneh FT; Alshbool FZ
Life Sci; 2020 Dec; 262():118481. PubMed ID: 32971104
[TBL] [Abstract][Full Text] [Related]
13. Dok-1 negatively regulates platelet integrin αIIbβ3 outside-in signalling and inhibits thrombosis in mice.
Niki M; Nayak MK; Jin H; Bhasin N; Plow EF; Pandolfi PP; Rothman PB; Chauhan AK; Lentz SR
Thromb Haemost; 2016 May; 115(5):969-78. PubMed ID: 26790499
[TBL] [Abstract][Full Text] [Related]
14. A Novel Antibody Targeting the Second Extracellular Loop of the Serotonin 5-HT2A Receptor Inhibits Platelet Function.
Ramirez JEM; Alarabi AB; Khasawneh FT; Alshbool FZ
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955928
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant drugs in convulsive seizures: Pre-clinical evaluation of duloxetine in mice.
Santana-Coelho D; Souza-Monteiro JR; Paraense RSO; Busanello GL; Arrifano GPF; Mendonça JR; Silveira-Junior MEP; Royes LFF; Crespo-López ME
Neurochem Int; 2016 Oct; 99():62-71. PubMed ID: 27288549
[TBL] [Abstract][Full Text] [Related]
16. Plasma microRNA expression levels and their targeted pathways in patients with major depressive disorder who are responsive to duloxetine treatment.
Kim HK; Tyryshkin K; Elmi N; Dharsee M; Evans KR; Good J; Javadi M; McCormack S; Vaccarino AL; Zhang X; Andreazza AC; Feilotter H
J Psychiatr Res; 2019 Mar; 110():38-44. PubMed ID: 30580082
[TBL] [Abstract][Full Text] [Related]
17. Mice Expressing Low Levels of CalDAG-GEFI Exhibit Markedly Impaired Platelet Activation With Minor Impact on Hemostasis.
Piatt R; Paul DS; Lee RH; McKenzie SE; Parise LV; Cowley DO; Cooley BC; Bergmeier W
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1838-46. PubMed ID: 27417588
[TBL] [Abstract][Full Text] [Related]
18. Preclinical discovery of duloxetine for the treatment of depression.
Torres-Sanchez S; Perez-Caballero L; Mico JA; Elorza J; Berrocoso E
Expert Opin Drug Discov; 2012 Aug; 7(8):745-55. PubMed ID: 22680253
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of orally administered duloxetine in children and adolescents with major depressive disorder.
Lobo ED; Quinlan T; Prakash A
Clin Pharmacokinet; 2014 Aug; 53(8):731-40. PubMed ID: 24989060
[TBL] [Abstract][Full Text] [Related]
20. Morin hydrate inhibits platelet activation and clot retraction by regulating integrin α
Nam GS; Lee KS; Nam KS
Eur J Pharmacol; 2019 Dec; 865():172734. PubMed ID: 31614139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
